| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 65 |
| 1 | MYCOPHENOLATE MOFETIL | 55 |
| 2 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 55 |
| 3 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 55 |
| 4 | TACROLIMUS OINTMENT 0.1% | 55 |
| 5 | PREDNISOLONE | 48 |
| 6 | PREDNISOLONE ORAL | 48 |
| 7 | PREDNISOLONE ORAL SOLUTION | 48 |
| 8 | PREDNISONE | 34 |
| 9 | METHOTREXATE SODIUM | 33 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DIFLUPREDNATE OPHTHALMIC | 5 | 0.0056 |
| 1 | GANCICLOVIR SODIUM | 27 | 0.0025 |
| 2 | ACYCLOVIR SODIUM | 3 | 0.0024 |
| 3 | LETERMOVIR | 5 | 0.0015 |
| 4 | VALGANCICLOVIR | 27 | 0.0014 |
| 5 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 11 | 0.0014 |
| 6 | DIFLUPREDNATE | 5 | 0.0013 |
| 7 | FOSCARNET SODIUM | 5 | 0.0012 |
| 8 | BASILIXIMAB | 11 | 0.0009 |
| 9 | PAMIDRONATE DISODIUM | 3 | 0.0009 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 44 | 0.0020 |
| 1 | CD38-directed Cytolytic Antibody [EPC] | 10 | 0.0017 |
| 2 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 5 | 0.0015 |
| 3 | Antimetabolite Immunosuppressant [EPC] | 14 | 0.0007 |
| 4 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 2 | 0.0005 |
| 5 | CD52-directed Cytolytic Antibody [EPC] | 8 | 0.0004 |
| 6 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 1 | 0.0004 |
| 7 | Phosphodiesterase 3 Inhibitor [EPC] | 2 | 0.0003 |
| 8 | Nucleoside Analog Antiviral [EPC] | 27 | 0.0003 |
| 9 | Selective T Cell Costimulation Blocker [EPC] | 1 | 0.0002 |